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  A b s t r a c t
   Background/Aims:  The aim of this study was to compare differences in morphological and 
functional changes in brain regions in individual patients with progressive supranuclear palsy 
(PSP) and correlate their Mini-Mental State Examination (MMSE) score with anatomy and func-
tion using magnetic resonance imaging (MRI) and   18 F-fluorodeoxyglucose positron emission 
tomography (FDG-PET).  Methods:  Sixteen PSP patients and 20 age-matched healthy volunteers 
underwent FDG-PET and 3-dimensional MRI. Gray matter, white matter and metabolic activity 
were compared between patients and normal controls. In addition, possible correlations be-
tween the MMSE score and brain function/anatomy were examined.   Results:  The PSP group 
had reduced cerebral glucose metabolism, and lower gray and white matter volumes in the 
frontal lobes and midbrain compared with normal controls. In PSP subjects, the metabolic 
changes observed in the PET scans were greater than the loss in gray and white matter ob-
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served in the MRI scans. The MMSE scores were positively correlated with volume and FDG up-
take in the frontal lobe.   Conclusion:  FDG-PET is a more effective tool in the diagnosis of PSP 
than MRI. Atrophy and hypometabolism in the frontal lobe are as important as in the basal mid-
brain for differentiating PSP patients who primarily exhibit cognitive dysfunction from normal 
controls.     Copyright © 2011 S. Karger AG, Basel
  Introduction
  Progressive supranuclear palsy (PSP) is the second most common cause of parkinsonism 
 [1, 2] . Common symptoms of PSP include parkinsonism with progressive vertical gaze palsy, 
postural instability with falls, akinesia, and cognitive impairment   [3, 4]  . Further, PSP causes 
neuronal degeneration in the brainstem, including in the substantia nigra, tegmentum, and 
superior colliculus   [3]  ; tau pathology that accompanies tuft-shaped astrocytes   [5]   has also 
been observed in the superior and middle frontal gyri in PSP   [6]  .
  Earlier magnetic resonance imaging (MRI) studies have primarily used regions of inter-
est analyses to examine brain atrophy   [7–11]  . However, the results of such analyses depend 
largely on the arbitrary locus and size that examiners select retrospectively. Also, this meth-
od is time-consuming and only measures relatively large areas, potentially overlooking finer 
differences.
    Voxel-based analysis using statistical parametric mapping (SPM) was developed to ex-
amine focal differences in brain anatomy. This method can eliminate the effects of differ-
ences in size, and voxel-by-voxel comparison allows one to perform a prospective statistical 
analysis of differences in gray matter loss and changes in metabolism.
    Using voxel-based morphometry (VBM) with MRI   [12, 13]   and voxel-based positron 
emission tomography (PET) analysis   [14–18]   of PSP cases, reductions in gray matter and 
metabolic activity have been observed primarily in the frontal lobe and basal midbrain.
    However, patients in previous PET and MRI studies have differed with regard to the 
clinical stage of the disease. Thus, a comparison between the metabolic changes and decreas-
es in gray matter in patients is difficult to make. The strength of the present study is a direct 
comparison of fluorodeoxyglucose (FDG) and VBM in the same PSP subjects.
    Based on the success of large multicenter Alzheimer disease neuroimaging studies (e.g. 
ADNI and AIBL), there is increasing interest in neuroimaging measures as secondary or sur-
rogate markers of outcome for therapy trials on neurodegenerative diseases. The modality 
that can diagnose PSP in its early stages more adequately remains to be identified. The pri-
mary aim of this study was to compare the distribution of glucose hypometabolism and at-
rophy simultaneously in the same group of patients.
    PSP is a major cause of dementia. The cognitive disturbances that occur in PSP are re-
ferred to as subcortical dementia   [19, 20]  . PSP patients demonstrate significant deficits in 
recall and moderate forgetfulness, despite intact short-term and implicit perceptual mem-
ory   [19]  . PSP is also accompanied by memory loss and more common deficits, including 
executive dysfunction, decreased working memory, psychomotor slowing, non-fluent 
aphasia, and, at times, profound behavioral changes that mimic frontotemporal dementia 
 [21,  22] .
    Despite the clinical significance of dementia, no study has examined the brain struc-
tures that are affected during cognitive impairment in patients with PSP. In this study, we 
selected PSP patients with relatively mild cognitive impairment and examined the changes 
in the associated brain regions.383
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  Patients  and  Methods
  Patient  Selection
    In this study, we included 16 probable PSP patients [5 females and 11 males; age: 64.9 
(6.4) years; Mini-Mental State Examination (MMSE) score: 21.0 (4.4)] and 20 cognitively nor-
mal controls [8 females and 12 males; age: 64.8 (6.4) years; MMSE score: 29.8 (0.6)]. We se-
lected subjects retrospectively from the Dementia Registry, a database of our institute. These 
patients had been admitted to the infirmary at our institution between April 1996 and March 
2002 to undergo an evaluation for dementia and had agreed to be registered in the database; 
they were followed up for   1  2 years. In order to ensure that the imaging protocols and the 
types of PET and MRI scanners were the same throughout the observation period, we per-
formed the analyses with the instruments used initially.
    The normal controls were matched for sex and age. The institutional ethics board ap-
proved this study. The participants’ informed consents were obtained when they registered 
in the Dementia Registry database, but due to the retrospective design of this study informed 
consent was not required.
    The MMSE scores of the participants were calculated. All patients were examined by 
neurologists and psychiatrists and underwent standard neurological and neuropsychological 
examinations, laboratory tests, electroencephalography, cranial MRI, and   18 F-FDG-PET. The 
criteria for PSP of the National Institute of Neurological Disorders and Stroke Society were 
used to select patients for inclusion: a gradually progressive disorder; onset at   6  40 years of 
age; vertical (upward and downward gaze) supranuclear palsy and prominent postural insta-
bility with falls in the 1st year of the disease, and no evidence of other diseases that could 
explain the features above. Our patient group had mild cognitive impairment [MMSE score: 
21.0 (4.4)].
  All patients fulfilled the criteria for probable PSP, and all subjects who were included had 
been followed up for   6  3 years after study entry. The diagnosis of PSP was confirmed in all 
cases at the follow-up evaluation. The patients’ characteristics’, including extrapyramidal 
signs, parkinsonism, and cortical symptoms, are shown in   table 1  . All control subjects had 
MMSE scores   6  28 and exhibited no clinical evidence of cognitive deficits or neurological 
disease. W e did not detect any abnormal findings with regard to age-related atrophy or 
changes in white matter, including white matter hyperintensities.
 Females/males  5/11 
  Mean age, years    64.6  8  6.4 
  Mean MMSE score    21.0  8  4.4 
  Lim rigidity, n    11 (69%) 
  Postural instability, n    16 (100%) 
  Apraxia, n  0 (0%) 
  Cortical sensory loss, n  0 (0%) 
  Alien limb, n  0 (0%) 
  Myoclonus, n  0 (0%) 
  Tremor, n  1 (6%) 
  Hyperreflexia, n  7 (44%) 
  Babinski’s sign, n  5 (31%) 
  Supranuclear palsy, n    16 (100%) 
  Axial dystonia or rigidity, n    16 (100%) 
  Pseudobulbar palsy, n    14 (88%) 
 
 
  Table  1.    Characteristics and 
symptoms of the 16 PSP patients 
 384
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  Magnetic  Resonance  Imaging
    A 1.5-tesla Signa Horizon MRI system was used for this study (GE Medical Systems, 
Milwaukee, Wisc., USA). Sagittal, coronal, and axial T  1 -weighted spin echo images (TR/TE/
NEX: 550/15/2; 5 mm thick, 2.5-mm gap) and axial T  2 -weighted fast spin echo images 
(3,000/21,105/2) were obtained to detect abnormalities. VBM analyses were conducted using 
coronal 3D spoiled gradient echo (SPGR) images  [23, 24] (14/3/2, 20° flip angle, 220-mm field 
of view, 256   !   256 matrix, 124   !   1.5 mm contiguous sections). The 3D-SPGR images were 
constructed with a voxel size of 0.86   !   0.86   !   1.5 mm. Then, the images were reconstruct-
ed into 2.0-mm isotropic voxel images by the SPM/VBM methods.
  Positron  Emission  Tomography
    The detailed PET procedure has been described previously   [15]  . In brief, FDG-PET im-
ages were obtained using a Headtome IV scanner (Shimadzu, Kyoto, Japan). All subjects 
fasted for at least 4 h before the PET scan. The subjects were examined in the resting condi-
tion with their eyes closed and ears unplugged. After a transmission scan, a 12-min emission 
scan was started 60 min after an intravenous injection of 185–370 MBq FDG. The data were 
collected in 128   !   128 matrices. The slice number was 14, and the slice interval was 6.5 mm 
in the z-motion mode.
  D a t a   A n a l y s i s
    Anatomical normalization and statistical processing of the PET and MR images were 
performed using SPM for Windows, version 8 (SPM 8; Wellcome Department of Cognitive 
Neurology, London, UK). The calculations and image matrix manipulations were performed 
using MATLAB R2009b (MathWorks, Natick, Mass., USA).
    For the VBM analysis using SPM 8, all coronal SPGR MRI datasets were reconstructed 
into axial datasets and subsequently converted to ANALYZE format and displayed with the 
right hemisphere on the right side of the image.
    The MRI data were analyzed using VBM, implemented in SPM 8. First, conventional 
VBM was performed using the default template. Next, we applied DARTEL (an algorithm 
for accurate diffeomorphic image registration), implemented as a toolbox in SPM 8, to create 
a set of group-specific templates. Using these templates, the brain images were segmented, 
normalized, and modulated. The output images remained in the average brain space. Addi-
tional warping from the Montreal Neurological Institute space was provided to the brain 
images. Finally, the gray matter probability values were smoothed using an 8-mm full-width 
at half maximum Gaussian kernel to match the PET analysis. The DARTEL procedure, in 
addition to the previous spatial normalization methods that were developed by Ashburner 
 [25] ,    improves  anatomical  precision   [26] .
  For FDG-PET, all individual PET images were co-registered with MRI. The images were 
transformed into a standard stereotactic anatomical space using the DARTEL flow that was 
created in the MRI normalization. Further, all PET and MRI images were smoothed using 
an isotropic 8-mm Gaussian kernel to increase the signal-to-noise ratio and compensate for 
differences in gyral anatomy between individuals. The individual FDG images were adjust-
ed by proportional scaling to a mean value of 5.0 mg 100 ml  –1  min  –1 .
    The metabolic activity, gray matter, and white matter were compared between patients 
and controls and analyzed by a 2-sample t test. The correlations between MMSE scores and 
brain structures were then examined with regard to metabolic activity, gray matter, and 
white matter by voxel-wise regression analysis, considering total intracranial volume, gen-
der, and age as nuisance parameters.
    Each comparison between patients and controls was analyzed by a statistical design in 
the 2-sample t test. In this study, we applied an uncorrected threshold of p   !   0.001 on the 385
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basis of the results obtained in the previous studies, in which the frontal lobes and the mid-
brain were found as the regions of hypometabolism  [15–18]  or decreased gray matter  [12, 13]  
in patients with PSP.
  R e s u l t s
    Comparison with Normal Controls
    Using FDG-PET, we observed a reduction in metabolic activity in the bilateral frontal 
lobes and midbrain tegmentum in the PSP group compared with normal controls (p  !   0.001, 
uncorrected;   fig. 1 a).
    In the MRI VBM study, we compared gray matter volume in the bilateral frontal lobes, 
anterior cingulate gyrus, right middle temporal gyrus, and right midbrain between patients 
and normal controls (p  !   0.001, uncorrected;  fig. 1 b;  table 2 ). White matter volume decreased 
significantly in the bilateral thalami, midbrain tegmentum, and right frontal lobes (p   !   
0.001, uncorrected;   fig. 1  c;   table 2  ). The decrease in white matter in the midbrain was more 
marked than the reduction in gray matter in the visual analysis.
  F i g .  1.   SPM in patients and age-matched healthy controls.   a  Areas showing significantly lower hypome-
tabolism in PSP patients are highlighted (p   !   0.001, uncorrected). PET analysis of metabolic reductions 
in bilateral frontal lobes and midbrain tegmentum in the PSP group and normal controls.  b  Areas show-
ing significant reductions in gray matter (GM) in PSP patients are highlighted (p  !   0.001, uncorrected). 
Gray matter volume in the bilateral frontal lobes, anterior cingulate gyrus, right middle temporal gyrus, 
and right midbrain in PSP patients and normal controls.   c  Areas showing significant reductions in 
white matter (WM) in PSP patients are highlighted (p   !   0.001, uncorrected). White matter volume in 
the bilateral thalami, midbrain tegmentum, and right frontal lobes.
 386
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    The extent to which the white matter decreased was less than the decrease in hypome-
tabolism in PSP patients. The decreases in gray and white matter in the midbrain tegmentum 
were comparable.
    Metabolic and Structural Correlations with MMSE
    A positive metabolic and structural correlation with MMSE was observed in the left 
frontal lobe in regression analysis (p   !   0.001, uncorrected;   fig. 2  ;   table 3  ). Additional reduc-
tions in gray matter were noted in the right frontal lobe and bilateral rectal gyri (  fig. 2  ;   ta-
ble 3 ).
  Representative  Cases
      Figure 3   shows MR (  fig. 3  a) and FDG-PET (  fig. 3  b) images of a male patient with PSP 
(MMSE score: 23) and a normal female subject (MMSE score: 30) of the same age (68 years). 
Slight midbrain and bilateral frontal lobe atrophy was observed on visual inspection of the 
conventional T  1 -weighted image of the PSP patient compared with the healthy control 
  Table  2.    Regions showing significant differences between PSP patients and controls
 Comparison   Brain  region   T alairach  coordinates   t  value 
 side   x   y   z   
 FDG-PET:  PSP  <  NC   Thalamus   R  8   –22   12   7.12 
 Middle  frontal  gyrus   L   –38  54  8   6.71 
 Lateral  frontal  lobe   L   –50  16  3   5.07 
 Lateral  frontal  lobe   R  54  17   –4   6.60 
 Medial  frontal  lobe   R  6  40   24   6.02 
  Gray matter: PSP < NC    Lateral frontal lobe    R  38  9    29    5.46 
 Inferior  frontal  gyrus   R  49  22   19   3.60 
 Middle  temporal  gyrus   R  53   –25   –8   5.26 
 Anterior  cingulate  gyrus   R  17  4   44   4.95 
 Midbrain   L   –16   –16   –5   4.12 
 Lateral  frontal  lobe   L   –34  20  8   5.22 
 Anterior  cingulate  gyrus   L   –13  15   39   4.22 
 White  matter:  PSP  <  NC   Thalamus   R  8   –16  6   6.14 
 Thalamus   L  –8   –15  1   5.58 
 Lateral  frontal  lobe   R  34  27   19   6.24 
 Midbrain   L  –4   –18   –5   4.32 
 Midbrain   R  12   –15   –9   4.14 
 
 
  Table  3.    Regions that correlate with MMSE score in PSP patients
 Brain  region   T alairach  coordinates   t  value 
 si de   x   y   z 
 FDG-PET   Middle  frontal  gyrus   L   –38   35  26   4.77 
 Gray  matter   Anterior  cingulate  gyrus   L  –6   25  27   5.36 
 Rectal  gyrus   L  –5   27  15   4.43 
 Rectal  gyrus   R  9   24   –16   4.37 
 Middle  frontal  gyrus   L   –36   48  12   4.56 
 White  matter   Inferior  frontal  gyrus   L   –37   35  3   6.97 
 Middle  frontal  gyrus   L   –23   39  20   5.24 
 
 387
Dement Geriatr Cogn Disord Extra 2011;1:381–392
 DOI:  10.1159/000333368 
EXTRA
  Takahashi et al.: Brain Alterations and MMSE in Progressive Supranuclear Palsy 
www.karger.com/dee
  © 2011 S. Karger AG, Basel 
  Published online: November 9, 2011     
( fig. 3 a); however, the PSP patient experienced more severe hypometabolism in the midbrain 
and bilateral frontal lobes, including the medial and lateral frontal lobes.
      Figure 4   shows the MR (  fig. 4  a) and FDG-PET (  fig. 4  b) images of a demented male pa-
tient with PSP (MMSE score: 17) and a normal female subject (MMSE score: 30) of the same 
age (70 years). Abnormalities in the midbrain were not observed on visual inspection of the 
conventional T  1 -weighted image and FDG-PET images of the PSP patient compared with the 
healthy control; however, slight atrophy and more severe hypometabolism were noted in the 
PSP patient in the bilateral frontal lobes (  fig. 4  ).
  Discussion
    This study is the first head-to-head comparison of FDG and VBM in the same group 
of PSP subjects. The FDG-PET and MRI scans showed that relatively similar regions expe-
rienced significant reductions in metabolic activity, gray matter, and white matter – pri-
marily the frontal lobe and midbrain tegmentum. First, the visual extents of the regions in 
which there were significant changes were much greater on FDG-PET than on MRI. Fur-
ther, the correlation between the frontal lobe and MMSE scores in PSP patients was similar 
in all evaluations. The midbrain tegmentum was not linked to the MMSE score in any 
evaluation.
  Fi g .  2 .   Areas of significant positive correlations with MMSE scores in patients with PSP (p  !   0.001, uncor-
rected). Correlations with metabolism (  a ), gray matter (GM) volume (  b ), and white matter (WM) volume 
( c ). The left frontal lobe is highlighted in all analyses. Additional gray matter reduction is detected in the 
bilateral rectal gyri.388
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    Comparison between Cortical Atrophy and Hypometabolism in PSP Patients
  Compared with atrophy, the cluster volume of gray matter hypometabolism was greater, 
which implies that FDG-PET is more important in the differential diagnosis of PSP.
  FDG-PET revealed hypometabolism in the bilateral frontal lobes and midbrain tegmen-
tum, in agreement with previous PET studies   [14–18]  .
    VBM analysis disclosed significant reductions in gray matter in the lateral frontal lobe, 
including the middle and inferior frontal gyri, midbrain, and middle frontal gyrus. These 
results are consistent with previous VBM studies   [12, 13]  . Additional gray matter reductions 
in the hippocampus and parahippocampal gyrus were noted in another study  [12] . The clus-
ter volume in our study appeared to be smaller than in previous VBM studies.
    The problem in previous VBM studies has been the misregistration of structures   [27]  . 
Such misregistrations could be observed in the periventricular area and the deep brain struc-
tures, such as the striatal nucleus and brainstem  [27] . The DARTEL method was quite useful 
to reduce the registration errors in these areas   [26]  . The greater reduction in midbrain gray 
matter (compared with white matter) that was observed in one study  [12]  might be explained 
by the misregistration of structures.
    However, there would be some space to discuss the structural changes in the midbrain. 
In this study, T  1 -weighted imaging was used for VBM analysis. The brainstem has many nu-
clei with iron deposition. T  1 -weighted imaging is less sensitive to changes in iron deposits in 
the brainstem, which complicates the discrimination of MR signals between gray matter and 
white matter in the brainstem. This would directly affect the segmentation process in VBM. 
Another study that used surface rendering without segmenting the gray and white matter 
  Fi g .  3 .   Comparisons between the MRI ( a ) and FDG-PET ( b ) images of a 68-year-old male patient with PSP 
(MMSE score = 23) and a normal age-matched female control (NC; MMSE score = 30): slight atrophy in 
the midbrain and bilateral frontal lobes (  a ). More severe hypometabolism in the midbrain and bilateral 
frontal lobes, including the medial and lateral frontal lobes (  b ). The white arrows indicate the suspected 
abnormalities.389
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observed brainstem atrophy in PSP patients   [28]  ; however, due to limitations in measuring 
the volumes of regional structures, a new method for measuring brainstem atrophy in PSP 
should be developed 
    Our procedure – VBM using DARTEL – revealed greater reductions in the white than 
in the gray matter in the midbrain tegmentum. Further, the cluster volume of gray matter 
hypometabolism was much higher compared with gray matter atrophy in PSP patients.
    Brain Structures Correlate with Cognitive Impairment in PSP Patients
  We are the first to correlate brain structures and cognitive impairment in PSP. The fron-
tal lobe was detected in all regression analyses. Our results show that atrophy and hypome-
tabolism in the frontal lobe are as important as in the basal midbrain in the diagnosis of PSP 
patients exhibiting cognitive dysfunction. In fact, as shown in   figure 4  , we identified a de-
mented PSP patient who only experienced hypometabolism and atrophy in the frontal lobe 
but not in the basal midbrain. If we consider PSP with regard to dementia, disease progres-
sion in the frontal lobe versus the midbrain is not synchronized.
    The cognitive changes that occur in PSP are referred to as subcortical dementia, which 
is associated with cognitive impairment, including prominent deficits in recall and moderate 
forgetfulness, despite intact short-term and implicit perceptual memory   [19]  . These symp-
toms are similar to those in patients with frontal lobe dysfunction. Neuropsychological stud-
ies employing the Frontal Behavioral Inventory suggest the presence of frontal lobe dysfunc-
tion in PSP patients   [29]  .
  Fi g .   4 .   MR (  a ) and FDG-PET (  b ) images of a demented male patient with PSP (MMSE score: 17) and a 
normal age-matched female control (NC; MMSE score: 30; 70 years). The white arrows indicate the sus-
pected abnormalities in the frontal lobes. 390
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